Prevention of anastrozole induced bone loss with monthly oral ibandronate: Final 5 year results from the ARIBON trial

PURPOSE: The ARIBON trial is a double blind, randomised, placebo controlled study designed to evaluate the impact of ibandronate on bone mineral density (BMD) in women taking anastrozole for adjuvant treatment of breast cancer. METHODS: 131 postmenopausal women with early breast cancer were recruite...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Bone Oncol
Autors principals: Lester, J.E., Dodwell, D., Brown, J.E., Purohit, O.P., Gutcher, S.A., Ellis, S.P., Thorpe, R., Horsman, J.M., Coleman, R.E.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4723320/
https://ncbi.nlm.nih.gov/pubmed/26909256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2012.06.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars